Longevity Programme Assessment (LPA)

Nuffield Medical's structured Longevity Programme Assessment combines advanced biomarker testing with doctor-led review to map biological age and optimise long-term healthspan. Designed as an entry point into the clinic's ongoing longevity care pathway.

The Longevity Programme Assessment (LPA) at Nuffield Medical is a flagship offering that brings together the clinic's diagnostic and therapeutic capabilities into a single, cohesive protocol. It begins with an extended doctor consultation to understand the patient's health history, lifestyle, and longevity goals. A curated advanced biomarker panel is then ordered, covering inflammation markers (hs-CRP, homocysteine), metabolic health (fasting insulin, HbA1c, lipid sub-fractions), hormonal balance (testosterone, DHEA-S, oestradiol, cortisol, SHBG), nutritional status (vitamin D, B12, folate, iron, zinc, magnesium), and organ function baselines. Depending on findings, the doctor may recommend complementary interventions such as hormone replacement therapy, IV nutrient infusions, or NAD+ therapy to address identified deficiencies and optimise cellular function. The LPA framework is suitable for adults aged 35 and above who want a proactive, personalised approach to preventive medicine. Follow-up reassessments are recommended every 6–12 months to track progress and adjust the protocol. The programme is available at both the Orchard and Siglap locations, with the Orchard clinic serving as the primary longevity hub. Nuffield Medical's LPA positions the clinic as a credible entry point for medical longevity in Singapore, grounded in evidence-based protocols rather than unregulated supplements.